VeroScience, LLC

The US Food and Drug Administration is requiring labeling changes, but not boxed warnings, for some dopamine agonists to better reflect the risks of impulse control disorders (ICD) and other psychiatr

The consumer group Public Citizen is taking its dispute with the US Food and Drug Administration over labeling for dopamine agonist products to court. In a lawsuit filed 29 April, the group seeks to

Biopharmaceutical, medical device, and in vitro diagnostics start-up dealmaking from July through September 2010. Data from Elsevier's Strategic Transactions. Deanna F. Kamienski Financings In the thi

In Vitro Diagnostics Acquisitions /In Vitro Diagnostics Abbott Laboratories Inc. Celera Corp. In a four-year deal, Celera Corp. has licensed Abbott Laboratories Inc. exclusive rights to distri